Sat.May 31, 2025

article thumbnail

At ASCO, Enhertu cements growing role in stomach cancer care

BioPharma Drive: Drug Pricing

AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its importance as a second-line treatment option.

Treatment 241
article thumbnail

Feeling Work Stress? Your Dog Might Be Feeling It Too

Drugs.com

SATURDAY, May 31, 2025 Stress from work doesnt always stay at the office and it may be affecting more than just your mood. A new study finds that your dog may be picking up on it, too, especially if you have a hard time letting go of work worri.

204
204
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Full Arvinas, Pfizer data confirm potential and limits of ‘Protac’ drug in breast cancer

BioPharma Drive: Drug Pricing

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free survival was modest.

Treatment 170
article thumbnail

Oracle Fusion new Product Management Landing Page and AI (25B)

Perficient: Drug Development

We have been hearing about AI in many different ways and technology pioneers have been slowly introducing AI in our daily lives. When it comes to Fusion Applications, Oracle has invested in built-in AI capabilities across all platforms and Supply Chain area is not an exception. In this blog, I would like to discuss the newly designed Product Management Redwood Experience and a few AI capabilities that comes out of of the box.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

FDA clears Moderna’s new COVID vaccine, but with limits

BioPharma Drive: Drug Pricing

The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe disease.

Vaccine 249
article thumbnail

Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist

Chemical Biology and Drug Design

Despite significant research in the past decades, no EP4 antagonist has been approved for human use yet. The scaffold-hopping approach, in combination with docking studies, synthesis, and biological investigations, resulted in a nontoxic, potent compound 4 , which is metabolically stable, permeable, and orally bioavailable EP4 antagonist. ABSTRACT The prostaglandin E 2 (PGE 2 ) regulates several biological processes via interaction with 1 of 4 E-type prostanoid receptors (EP1EP4).